Elevance Health, Inc. — Director's Dealing 2021

Mar 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2021-03-01

Reporting Person: Alter Jeffrey D. (EVP, IngenioRx & Anthem Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-01	Common Stock	A	2649	—	Acquired	5395	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-01	Employee Stock Option (Right to Buy)	$311.48	A	10876	Acquired	2031-03-01	Common Stock (10876.0)	Direct

Footnotes

F1: Represents restricted share units. Restrictions lapse as follows: 883 shares each on 3/1/2022, 3/1/2023 and 3/1/2024.

F2: The option represents a right to purchase a total of 10,876 shares, and is exercisable in three annual installments, with two installments of 3,625 shares each and one installment of 3,626 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date.